š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The study is being conducted to evaluate the efficacy, and safety of camrel...
Status
Unknown
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2022-09-08
Trial ID
NCT05042375
Treatments Being Tested
The primary objective of the study was to assess the effect of repeated ora...
Status
Completed
Location
Affiliated Hospital of Qingdao University
Start Date
2020-07-20
Trial ID
NCT04494659
Treatments Being Tested
This is a single-center, randomized, open-label study to compare the pharma...
Status
Completed
Location
Xiangya Hospital Central South University
Start Date
2021-09-23
Trial ID
NCT05046808
Famitinib is a novel oral multitargeted tyrosine kinase inhibitor with anti...
Status
Completed
Location
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Start Date
2009-06
Trial ID
NCT01762280
Treatments Being Tested
The study is a single-centre, randomized, open, 2-period, 2-sequence crosso...
Status
Completed
Location
The First Affiliated Hospital of USTC
Start Date
2022-05-11
Trial ID
NCT05336279
To assess the safety and tolerability of SHR-1802 combined with camrelizuma...
Status
Terminated
Location
Tianjin Medical University Cancer Institute&Hospital
Start Date
2022-04-22
Trial ID
NCT05208177
Treatments Being Tested
The study is being conducted to evaluate the efficacy and safety of famitin...
Status
Terminated
Location
307 Hospital of PLA
Start Date
2020-09-12
Trial ID
NCT04409223
Treatments Being Tested
This is a phase II, open-label, multi-cohort study, aiming to investigate s...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2021-09
Trial ID
NCT05005468
Treatments Being Tested
The primary objective is to evaluate the bioequivalence of famitinib malate...
Status
Completed
Location
Xuanwu Hospital Beijing, Capital Medical University
Start Date
2020-05-27
Trial ID
NCT04400123
Treatments Being Tested
This is a randomized, open-label, international, multi-center, phase III tr...
Status
Terminated
Location
Subei People's Hospital of Jiangsu Province
Start Date
2022-01-06
Trial ID
NCT05106335
Treatments Being Tested